| Scott Greenberg, | |
|
101 Plain St Ste 101, Providence, RI 02903-4828 | |
| (401) 274-5844 | |
| Not Available |
| Full Name | Scott Greenberg |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 9 Years |
| Location | 101 Plain St Ste 101, Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952789018 | NPI | - | NPPES |
| 00274364 | Medicaid | NY |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rhode Island Hospital | Providence, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Retina Consultants Inc | 0749295525 | 2 |
| Lifespan Physician Group Inc | 2567455082 | 631 |
| Retina Consultants Inc | 0749295525 | 2 |
News Archive
Kathryn Daniel believes nurses, who make up the largest segment of medical workers in the United States, are the backbone of the nation's health care system.
Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new way of identifying fresh market applications for drugs nearing the end of their product lifecycle.
It's long been known that people living with HIV experience a loss of white matter in their brains. As opposed to "gray matter," which is composed of the cell bodies of neurons, white matter is made up of a fatty substance called myelin that coats neurons, offering protection and helping them transmit signals quickly and efficiently.
Sagent Pharmaceuticals, a privately held specialty pharmaceutical company, announced today that it has raised $40 million through two tranches of a strategic Series B financing. In this round, a $10 million investment was made by Zhejiang Hisun Pharmaceutical Co. Ltd. (Hisun), and the remaining $30 million was contributed by an unnamed China-focused private equity investment fund. To date, including this financing, Sagent has raised $153 million in equity capital.
› Verified 1 days ago
| Entity Name | Retina Consultants Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780765354 PECOS PAC ID: 0749295525 Enrollment ID: O20091015000191 |
News Archive
Kathryn Daniel believes nurses, who make up the largest segment of medical workers in the United States, are the backbone of the nation's health care system.
Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new way of identifying fresh market applications for drugs nearing the end of their product lifecycle.
It's long been known that people living with HIV experience a loss of white matter in their brains. As opposed to "gray matter," which is composed of the cell bodies of neurons, white matter is made up of a fatty substance called myelin that coats neurons, offering protection and helping them transmit signals quickly and efficiently.
Sagent Pharmaceuticals, a privately held specialty pharmaceutical company, announced today that it has raised $40 million through two tranches of a strategic Series B financing. In this round, a $10 million investment was made by Zhejiang Hisun Pharmaceutical Co. Ltd. (Hisun), and the remaining $30 million was contributed by an unnamed China-focused private equity investment fund. To date, including this financing, Sagent has raised $153 million in equity capital.
› Verified 1 days ago
| Entity Name | Lifespan Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407116643 PECOS PAC ID: 2567455082 Enrollment ID: O20121029000368 |
News Archive
Kathryn Daniel believes nurses, who make up the largest segment of medical workers in the United States, are the backbone of the nation's health care system.
Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new way of identifying fresh market applications for drugs nearing the end of their product lifecycle.
It's long been known that people living with HIV experience a loss of white matter in their brains. As opposed to "gray matter," which is composed of the cell bodies of neurons, white matter is made up of a fatty substance called myelin that coats neurons, offering protection and helping them transmit signals quickly and efficiently.
Sagent Pharmaceuticals, a privately held specialty pharmaceutical company, announced today that it has raised $40 million through two tranches of a strategic Series B financing. In this round, a $10 million investment was made by Zhejiang Hisun Pharmaceutical Co. Ltd. (Hisun), and the remaining $30 million was contributed by an unnamed China-focused private equity investment fund. To date, including this financing, Sagent has raised $153 million in equity capital.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott Greenberg, 101 Plain St Ste 101, Providence, RI 02903-4828 Ph: (401) 274-5844 | Scott Greenberg, 101 Plain St Ste 101, Providence, RI 02903-4828 Ph: (401) 274-5844 |
News Archive
Kathryn Daniel believes nurses, who make up the largest segment of medical workers in the United States, are the backbone of the nation's health care system.
Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new way of identifying fresh market applications for drugs nearing the end of their product lifecycle.
It's long been known that people living with HIV experience a loss of white matter in their brains. As opposed to "gray matter," which is composed of the cell bodies of neurons, white matter is made up of a fatty substance called myelin that coats neurons, offering protection and helping them transmit signals quickly and efficiently.
Sagent Pharmaceuticals, a privately held specialty pharmaceutical company, announced today that it has raised $40 million through two tranches of a strategic Series B financing. In this round, a $10 million investment was made by Zhejiang Hisun Pharmaceutical Co. Ltd. (Hisun), and the remaining $30 million was contributed by an unnamed China-focused private equity investment fund. To date, including this financing, Sagent has raised $153 million in equity capital.
› Verified 1 days ago
Marjorie A. Murphy, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: One Hoppin Street, Suite 202, Providence, RI 02903 Phone: 401-831-4592 Fax: 401-831-4643 | |
Michael E Migliori, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1 Hoppin St, Suite 202, Providence, RI 02903 Phone: 401-444-6551 Fax: 401-444-6587 | |
Dr. Noelle Layer Pruzan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 623 Atwells Ave, Providence, RI 02909 Phone: 401-273-7100 | |
Dr. Harold Arthur Woodcome Jr., MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 101 Plain St Ste 101, Providence, RI 02903 Phone: 401-274-5844 Fax: 401-274-9462 | |
Joseph Francis Ducharme, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 78 Baker Street, Providence, RI 02905 Phone: 401-831-4592 Fax: 401-831-4643 | |
John P Donahue, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 150 E Manning St, Providence, RI 02906 Phone: 401-272-2020 Fax: 401-421-5979 | |
King Wai To, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: One Hoppin Street, Suite 202, Providence, RI 02903 Phone: 401-831-4592 Fax: 401-831-4643 |